ActiTrexx GmbH
PrivateLast Round
Series A
Mar 2, 2021
Total Funding Raised
$4.22M
Company Overview
ActiTrexx GmbH is a biotechnology company developing cellular and biologic therapies based on activated regulatory T cells to address T cell-mediated autoimmune and autoinflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ActiTrexx GmbH Comps
Public and private peers based on sector, stage, and business model.
ActiTrexx GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 2, 2021 |
ActiTrexx GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitions- und Strukturbank Rheinland-Pfalz | Series A |
| MediVentures | Series A |
| LBBW Venture Capital GmbH | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 35% MoM, from 66 to 89.
ActiTrexx GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ActiTrexx GmbH's valuation, stock price, and market status.
